SOURCE: The Medicines Company

The Medicines Company

October 28, 2013 21:16 ET

Second Annual Leadership Summit for Interventional Cardiologists Held in San Francisco

Faculty of Recognized Leadership Experts From Brandeis University, Yale University, Vocera Communications and The Medicines Company Join Panel of Leading Interventional Cardiologists From France, the Netherlands, Australia, China and the United States to Discuss the Process and Value of Leadership in Interventional Cardiology

SAN FRANCISCO, CA--(Marketwired - Oct 28, 2013) - Experts and panelists from around the world gathered in San Francisco today to continue a conversation about the development and role of physician leadership in interventional cardiology. An audience of cardiologists listened to and contributed to the debate about how doctors can be better leaders in order to improve both clinical and financial results of treatment in patients with angina and heart attacks.

Jon Chilingerian, PhD, Associate Professor of Human Services Management, Brandeis University, who moderated the program, said, "Based on our experience with our four-year, dual degree MD-MBA, our Brandeis Physician Leadership Programs and extant research, we have learned that physician leaders can make a significant difference in healthcare delivery outcomes and efficiency in hospitals, including in interventional cardiology. Our most effective hospitals successfully integrate educated physician leaders who are prepared to bring management science closer to clinical operations and medical decision-making. These physician leaders define a shared clinical vision and implement medical reforms that challenge assumptions, behaviors, and systems of authority. Preparing physician leaders should be a significant ingredient in every nation's health reform."

Thomas Kolditz, PhD, Retired Brigadier General, Yale School of Management Professor & Crisis Leadership Expert, added, "High risk situations are ideal settings to seek, find and develop great leaders. Interventional cardiology represents a high risk setting for, at least, the patient. Physicians and their teams need to practice inspired leadership in this setting."

Three million patients worldwide and approximately 750,000 in the United States undergo coronary angioplasty each year. The American Heart Association recommends teamwork for the procedure -- especially for heart attacks -- and according to leading experts, saving lives in the middle of the night demands effective leadership and a strong predilection for collaboration -- even sometimes a willingness to ask for help from cardiac surgeons. Furthermore, patient satisfaction and comfort has also been linked to faster recovery. Emerging data also link best leadership practices with improved patient mortality and morbidity rates as well as care efficiency measures in the treatment of heart attacks.

"We must make every effort to restore the human connection in healthcare," said M. Bridget Duffy, MD, Chief Medical Officer of Vocera Communications, Inc. "Building trust and relationships, improving communication and designing new models of care that bring physicians back to the patient bedside will improve both the human experience and outcomes. This is particularly impactful in high-tech situations such as interventional cardiology, where patients may otherwise be reduced to numbers and anonymous images. Our innovation network is partnering with leading healthcare organizations to build a new breed of physicians who are equipped to lead the effort to create a check list of clinical innovations that restore humanity back to healthcare."

Clive Meanwell, MD, PhD, Chairman and CEO of The Medicines Company, said, "Apparently leadership can take us to performance places new technologies cannot. It is increasingly obvious that in the brave new world of accountable healthcare, money, equipment and resources will go to those who can envision and articulate a better future and achieve goals with others."

The Second Annual Leadership Summit was produced by The Medicines Company with guidance from the faculty and panel. The symposium is part of a global educational platform that aims to assist those involved in interventional cardiology to acquire data and knowledge, along with various forms of behavior and competency that can potentially contribute to saving lives, alleviating suffering and improving healthcare efficiency in leading hospitals around the world.

Contact Information